Literature DB >> 22968890

Spending differences associated with the Medicare Physician Group Practice Demonstration.

Carrie H Colla1, David E Wennberg, Ellen Meara, Jonathan S Skinner, Daniel Gottlieb, Valerie A Lewis, Christopher M Snyder, Elliott S Fisher.   

Abstract

CONTEXT: The Centers for Medicare & Medicaid Services (CMS) recently launched accountable care organization (ACO) programs designed to improve quality and slow cost growth. The ACOs resemble an earlier pilot, the Medicare Physician Group Practice Demonstration (PGPD), in which participating physician groups received bonus payments if they achieved lower cost growth than local controls and met quality targets. Although evidence indicates the PGPD improved quality, uncertainty remains about its effect on costs.
OBJECTIVE: To estimate cost savings associated with the PGPD overall and for beneficiaries dually eligible for Medicare and Medicaid.
DESIGN: Quasi-experimental analyses comparing preintervention (2001-2004) and postintervention (2005-2009) trends in spending of PGPD participants to local control groups. We compared estimates using several alternative approaches to adjust for case mix.
SETTING: Ten physician groups from across the United States. PATIENTS AND PARTICIPANTS: The intervention group was composed of fee-for-service Medicare beneficiaries (n = 990,177) receiving care primarily from the physicians in the participating medical groups. Controls were Medicare beneficiaries (n = 7,514,453) from the same regions who received care largely from non-PGPD physicians. Overall, 15% of beneficiaries were dually eligible for Medicare and Medicaid. MAIN OUTCOME MEASURE: Annual spending per Medicare fee-for-service beneficiary.
RESULTS: Annual savings per beneficiary were modest overall (adjusted mean $114, 95% CI, $12-$216). Annual savings were significant in dually eligible beneficiaries (adjusted mean $532, 95% CI, $277-$786), but were not significant among nondually eligible beneficiaries (adjusted mean $59, 95% CI, $166 in savings to $47 in additional spending). The adjusted mean spending reductions were concentrated in acute care (overall, $118, 95% CI, $65-$170; dually eligible: $381, 95% CI, $247-$515; nondually eligible: $85, 95% CI, $32-$138). There was significant variation in savings across practice groups, ranging from an overall mean per-capita annual saving of $866 (95% CI, $815-$918) to an increase in expenditures of $749 (95% CI, $698-$799). Thirty-day medical readmissions decreased overall (-0.67%, 95% CI, -1.11% to -0.23%) and in the dually eligible (-1.07%, 95% CI, -1.73% to -0.41%), while surgical readmissions decreased only for the dually eligible (-2.21%, 95% CI, -3.07% to -1.34%). Estimates were sensitive to the risk-adjustment method.
CONCLUSIONS: Substantial PGPD savings achieved by some participating institutions were offset by a lack of saving at other participating institutions. Most of the savings were concentrated among dually eligible beneficiaries.

Entities:  

Mesh:

Year:  2012        PMID: 22968890      PMCID: PMC3484377          DOI: 10.1001/2012.jama.10812

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  24 in total

Review 1.  Clinical care and health disparities.

Authors:  B Starfield; J Gérvas; D Mangin
Journal:  Annu Rev Public Health       Date:  2012-01-03       Impact factor: 21.981

2.  Among dual eligibles, identifying the highest-cost individuals could help in crafting more targeted and effective responses.

Authors:  Teresa A Coughlin; Timothy A Waidmann; Lokendra Phadera
Journal:  Health Aff (Millwood)       Date:  2012-04-18       Impact factor: 6.301

3.  Medicare and Medicaid: conflicting incentives for long-term care.

Authors:  David C Grabowski
Journal:  Milbank Q       Date:  2007-12       Impact factor: 4.911

4.  Hospital use and mortality among Medicare beneficiaries in Boston and New Haven.

Authors:  J E Wennberg; J L Freeman; R M Shelton; T A Bubolz
Journal:  N Engl J Med       Date:  1989-10-26       Impact factor: 91.245

5.  Is health spending slowing down?

Authors:  H A Huskamp; J P Newhouse
Journal:  Health Aff (Millwood)       Date:  1994       Impact factor: 6.301

6.  Hospital readmission rates for cohorts of Medicare beneficiaries in Boston and New Haven.

Authors:  E S Fisher; J E Wennberg; T A Stukel; S M Sharp
Journal:  N Engl J Med       Date:  1994-10-13       Impact factor: 91.245

7.  The implications of regional variations in Medicare spending. Part 1: the content, quality, and accessibility of care.

Authors:  Elliott S Fisher; David E Wennberg; Thérèse A Stukel; Daniel J Gottlieb; F L Lucas; Etoile L Pinder
Journal:  Ann Intern Med       Date:  2003-02-18       Impact factor: 25.391

8.  Effects of nursing home ownership type and resident payer source on hospitalization for suspected pneumonia.

Authors:  R Tamara Konetzka; William Spector; Thomas Shaffer
Journal:  Med Care       Date:  2004-10       Impact factor: 2.983

9.  Case management for high-cost Medicare beneficiaries.

Authors:  J L Schore; R S Brown; V A Cheh
Journal:  Health Care Financ Rev       Date:  1999

10.  Risk adjustment of Medicare capitation payments using the CMS-HCC model.

Authors:  Gregory C Pope; John Kautter; Randall P Ellis; Arlene S Ash; John Z Ayanian; Lisa I Lezzoni; Melvin J Ingber; Jesse M Levy; John Robst
Journal:  Health Care Financ Rev       Date:  2004
View more
  54 in total

1.  Medicare Shared Savings Program: public reporting and shared savings distributions.

Authors:  John Schulz; Matthew DeCamp; Scott A Berkowitz
Journal:  Am J Manag Care       Date:  2015-08       Impact factor: 2.229

2.  Accountability across the Continuum: The Participation of Postacute Care Providers in Accountable Care Organizations.

Authors:  Carrie H Colla; Valerie A Lewis; Savannah L Bergquist; Stephen M Shortell
Journal:  Health Serv Res       Date:  2016-01-22       Impact factor: 3.402

3.  Measuring Success in Health Care Value-Based Purchasing Programs: Findings from an Environmental Scan, Literature Review, and Expert Panel Discussions.

Authors:  Cheryl L Damberg; Melony E Sorbero; Susan L Lovejoy; Grant R Martsolf; Laura Raaen; Daniel Mandel
Journal:  Rand Health Q       Date:  2014-12-30

4.  Effects of individual physician-level and practice-level financial incentives on hypertension care: a randomized trial.

Authors:  Laura A Petersen; Kate Simpson; Kenneth Pietz; Tracy H Urech; Sylvia J Hysong; Jochen Profit; Douglas A Conrad; R Adams Dudley; LeChauncy D Woodard
Journal:  JAMA       Date:  2013-09-11       Impact factor: 56.272

5.  Oregon's Medicaid Reform And Transition To Global Budgets Were Associated With Reductions In Expenditures.

Authors:  K John McConnell; Stephanie Renfro; Richard C Lindrooth; Deborah J Cohen; Neal T Wallace; Michael E Chernew
Journal:  Health Aff (Millwood)       Date:  2017-03-01       Impact factor: 6.301

Review 6.  Accountable care organizations and the practice of oncology.

Authors:  Steven J Bernstein
Journal:  J Oncol Pract       Date:  2013-05       Impact factor: 3.840

7.  Accountable Care Organizations in the United States: market and demographic factors associated with formation.

Authors:  Valerie A Lewis; Carrie H Colla; Kathleen L Carluzzo; Sarah E Kler; Elliott S Fisher
Journal:  Health Serv Res       Date:  2013-10-01       Impact factor: 3.402

8.  Team-based versus traditional primary care models and short-term outcomes after hospital discharge.

Authors:  Bruno D Riverin; Patricia Li; Ashley I Naimi; Erin Strumpf
Journal:  CMAJ       Date:  2017-04-24       Impact factor: 8.262

9.  Variation In Accountable Care Organization Spending And Sensitivity To Risk Adjustment: Implications For Benchmarking.

Authors:  Sherri Rose; Alan M Zaslavsky; J Michael McWilliams
Journal:  Health Aff (Millwood)       Date:  2016-03       Impact factor: 6.301

10.  Hospitals Participating In ACOs Tend To Be Large And Urban, Allowing Access To Capital And Data.

Authors:  Carrie H Colla; Valerie A Lewis; Emily Tierney; David B Muhlestein
Journal:  Health Aff (Millwood)       Date:  2016-03       Impact factor: 6.301

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.